Subcutaneous administration of neutralizing antibodies to endothelial monocyte-activating protein II attenuates cigarette smoke-induced lung injury in mice

EMAPII Monoclonal Antibody Ameliorates Influenza A Virus-Induced Lung Injury

(2018) Hongyan Lu et al.   MOLECULAR THERAPY

Autophagy in lung disease pathogenesis and therapeutics

(2015) Stefan W. Ryter et al.   Redox Biology

HIV envelope protein gp120-induced apoptosis in lung microvascular endothelial cells by concerted upregulation of EMAP II and its receptor, CXCR3

(2013) Linden A. Green et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6

(2013) Francesca Nazio et al.   NATURE CELL BIOLOGY

Pathogenesis of chronic obstructive pulmonary disease

(2012) Rubin M. Tuder et al.   JOURNAL OF CLINICAL INVESTIGATION

Lung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke–induced emphysema in mice

(2011) Matthias Clauss et al.   JOURNAL OF CLINICAL INVESTIGATION

Increased p53 Level, Bax/Bcl-xLRatio, and TRAIL Receptor Expression in Human Emphysema

(2008) Mathieu C. Morissette et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE